You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 2, January 12, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Trial Registration and the ICMJE

Since this article does not have an abstract, we have provided the first 135 words of the full text and any section headings.

To the Editor: We welcome the statement by the ICMJE1 on the need for prospective trial registration but would like to suggest the possibility of achieving full transparency of clinical trials by the publication in journals of study protocols and rationales. A prospective full description of the planned analyses may minimize post hoc analyses and thus serve the integrity of the results ultimately presented. Moreover, it is possible to describe the rationale, design, and ethical and safety issues of the study in much more detail than is required in trial registration or is possible in the final publication. Losing a "competitive edge" would be unlikely, since major clinical dilemmas under study usually need more than 1 large randomized trial before general acceptance and implementation; publishing full study protocols would be particularly suitable for multicenter trials.

Marc G. H. Besselink, MD
m.besselink@chir.azu.nl

Hein G. Gooszen, MD, PhD
Department of Surgery

Erik Buskens, MD, PhD
Julius Center for Health Sciences and Primary Care
University Medical Center Utrecht
Utrecht, the Netherlands

1. DeAngelis CD, Drazen JM, Frizelle FA, et al, International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004;292:1363-1364. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;293:157-158.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Clinical Trial Registration and the ICMJE
Rebecca Dresser
JAMA. 2005;293(2):157.
EXTRACT | FULL TEXT  

Clinical Trial Registration and the ICMJE
Omar Khalil, Rangaswamy Govindarajan, Mazin Safar, Laura Hutchins, and Paulette Mehta
JAMA. 2005;293(2):157.
EXTRACT | FULL TEXT  

Clinical Trial Registration and the ICMJE—Reply
Catherine D. DeAngelis
JAMA. 2005;293(2):158.
EXTRACT | FULL TEXT  

Clinical Trial Registration: A Statement From the International Committee of Medical Journal Editors
Catherine D. DeAngelis, Jeffrey M. Drazen, Frank A. Frizelle, Charlotte Haug, John Hoey, Richard Horton, Sheldon Kotzin, Christine Laine, Ana Marusic, A. John P. M. Overbeke, Torben V. Schroeder, Hal C. Sox, and Martin B. Van Der Weyden
JAMA. 2004;292(11):1363-1364.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.